CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) Stock Price

CLGNStock

$0.29−88.06%52W

Market Cap$5.48M

P/E—

PEG Ratio—

Div yield—

Beta0.75

CLGN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-62.73%

Price vs S&P 500 (4W)-11.29%

VGM Score20.51

Book Value / Share (Quarterly)$0.34

P/TBV (Annual)3.09x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)99.19%

Cash Flow / Share (Quarterly)$-0.79

Price vs S&P 500 (YTD)-90.47%

Gross Margin (TTM)-147.56%

Net Profit Margin (TTM)-3376.35%

EPS (TTM)$-1.03

10-Day Avg Trading Volume0.08M

EPS Excl Extra (TTM)$-1.03

Revenue Growth (5Y)-17.33%

EPS (Annual)$-0.94

ROI (Annual)-123.35%

Gross Margin (Annual)70.39%

Net Profit Margin (5Y Avg)-1883.09%

Cash / Share (Quarterly)$0.30

Revenue Growth QoQ (YoY)-96.45%

ROA (Last FY)-88.77%

Revenue Growth TTM (YoY)-84.26%

EBITD / Share (TTM)$-0.94

ROE (5Y Avg)-65.77%

Operating Margin (TTM)-3329.05%

Cash Flow / Share (Annual)$-1.27

P/B Ratio1.21x

P/B Ratio (Quarterly)1.58x

Net Income / Employee (Annual)$-294,600

EV / Revenue (TTM)4.23x

Net Interest Coverage (TTM)-40.21x

ROA (TTM)-102.02%

EPS Incl Extra (Annual)$-0.94

Current Ratio (Annual)4.44x

Quick Ratio (Quarterly)1.99x

3-Month Avg Trading Volume0.07M

52-Week Price Return-88.06%

Revenue / Employee (TTM)$10,000

Tangible BV / Share (Quarterly)$0.33

P/S Ratio (Annual)2.49x

Asset Turnover (Annual)0.03x

52-Week High$3.18

Operating Margin (5Y Avg)-1920.42%

EPS Excl Extra (Annual)$-0.94

CapEx CAGR (5Y)-44.25%

26-Week Price Return-51.48%

Quick Ratio (Annual)4.29x

13-Week Price Return-28.45%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.27x

Enterprise Value$1.65M

Revenue / Share Growth (5Y)-26.26%

Asset Turnover (TTM)0.03x

Book Value / Share Growth (5Y)10.26%

Revenue / Employee (Annual)$60,800

Inventory Turnover (Annual)2.32x

Pretax Margin (Annual)-484.56%

Cash / Share (Annual)$1.04

3-Month Return Std Dev93.10%

Gross Margin (5Y Avg)31.26%

Net Income / Employee (TTM)$-336,800

ROE (Last FY)-123.35%

Net Interest Coverage (Annual)-28.00x

EPS Basic Excl Extra (Annual)$-0.94

Receivables Turnover (TTM)97.25x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.03

Receivables Turnover (Annual)6.87x

ROI (TTM)-160.28%

P/S Ratio (TTM)15.19x

Pretax Margin (5Y Avg)-1883.09%

Revenue / Share (Annual)$0.19

Tangible BV / Share (Annual)$1.16

Price vs S&P 500 (52W)-106.37%

Year-to-Date Return-78.51%

5-Day Price Return-4.33%

EPS Normalized (Annual)$-0.94

ROA (5Y Avg)-41.38%

Net Profit Margin (Annual)-484.56%

Month-to-Date Return10.26%

Cash Flow / Share (TTM)$-0.50

EBITD / Share (Annual)$-0.87

Operating Margin (Annual)-484.31%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-65.77%

EPS Basic Excl Extra (TTM)$-1.03

P/TBV (Quarterly)1.60x

P/B Ratio (Annual)3.06x

Inventory Turnover (TTM)1.42x

Pretax Margin (TTM)-3376.35%

Book Value / Share (Annual)$1.18

Price vs S&P 500 (13W)-31.24%

Beta0.75x

P/FCF (Annual)6.49x

Revenue / Share (TTM)$0.03

ROE (TTM)-160.28%

52-Week Low$0.27

vGradeC

gGradeF

mGradeF

vgmGradeD

CLGN Earnings Surprise History

Q1 25-0.13est. -0.04

Q2 25-0.28est. -0.10

Q3 25-0.27est. 0.15

Q4 25-0.25est. -0.19

CLGN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	C	F	F	$0.29
ISRGIntuitive Surgical Inc.	D	B	D	$371.84
EWEdwards Lifesciences Corp	D	C	B	$90.87
STESTERIS plc	C	B	C	$236.44
ZBHZimmer Biomet Holdings, Inc.	B	C	C	$100.24
SNNSmith & Nephew plc	B	C	D	$29.22
ALGNAlign Technology Inc	B	D	C	$159.61
MSAMine Safety Incorporated	C	C	C	$187.69
ESTAEstablishment Labs Holdings Inc.	F	A	C	$72.15
ENOVEnovis Corporation	B	D	C	$25.58
CDRECadre Holdings, Inc.	C	C	C	$31.39
AVNSAvanos Medical, Inc.	B	D	C	$24.99
AVRAnteris Technologies Global Corp. Common Stock	F	D	B	$8.89
SMTISanara MedTech Inc. Common Stock	D	C	B	$34.67
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	B	D	C	$2.77
CNXUConexeu Sciences Inc. Common Stock	—	—	F	$7.55
INGNInogen Inc	B	D	D	$5.54
LAKELakeland Industries Inc	B	D	C	$11.52
SPAISafe Pro Group Inc. Common Stock	F	C	B	$5.25
NTRBNutriband Inc. Common Stock	F	D	B	$4.83
MYOMyomo Inc.	C	B	B	$1.48
COCHEnvoy Medical, Inc. Class A Common Stock	D	D	C	$0.75
APTAlpha Pro Tech, Ltd.	A	D	C	$5.36
MLSSMilestone Scientific, Inc. Common Stock	D	D	B	$0.48
LFWDLifeward Ltd. Ordinary Shares	B	D	C	$7.39
RGNTRegentis Biomaterials Ltd.	—	—	C	$2.09
HSCSHeartSciences Inc. Common Stock	F	F	B	$3.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	C	$2.92
FEEDENvue Medical, Inc. Common Stock	A	F	F	$0.39
BBLGBone Biologics Corp Common Stock	—	—	F	$0.60
BBLGWBone Biologics Corp Warrants	—	—	D	$8.24
COCHWEnvoy Medical, Inc Warrant	—	—	F	$0.04
HSCSWHeartSciences Inc. Warrant	—	—	F	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	$0.50

About CollPlant Biotechnologies Ltd Ordinary Shares

CollPlant Biotechnologies develops regenerative and aesthetic medicine solutions using its proprietary plant-based rhCollagen technology for 3D bioprinting and tissue engineering applications. The company generates revenue through BioInk product sales, rhCollagen therapeutics for aesthetics and medical indications, and strategic partnerships. Its primary markets span the United States, Europe, Canada, and Israel, targeting opportunities in tissue repair, organ manufacturing, and medical aesthetics.